Transcriptome analysis of a drug combination in two patient-derived xenograft (PDX) tumors of pancreatic cancer

ABSTRACT: We report that eight gene products were downregulated in PA4 and PA16 PDX models by BET inhibitor JQ1 + gemcitabine, compared to vehicle controls.

ORGANISM(S): Homo sapiens

PROVIDER: GSE174023 | GEO | 2021/07/28

REPOSITORIES: GEO